Christopher J. Tovey, Chief Operating Officer at GW PHARMACEUTICALS PLC (GWPH), sold 401,472 shares at $16.14 ($6.5M) on 2019-05-07, disclosed to the SEC on 2019-05-09.
Open-market sale of $6.5M GWPH by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.14 | 200,736 | $3.2M | 50.0% |
| 2 | $16.14 | 200,736 | $3.2M | 50.0% |
| Total | $16.14 avg | 401,472 | $6.5M | 100% |
| Filing → |
| GWPH | SELL | 2019-06-05 | $947K | — | Filing → |
| GWPH | SELL | 2019-05-17 | $18K | — | Filing → |